AMN Healthcare Services, Inc. logo

AMN Healthcare Services, Inc.

AMN

NYSEHealthcareMedical - Care Facilities

Regular session

$34.175

−$0.285 · -0.83%

Aug 24, 3:08 PM ET

AMN company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

69

Undervalued

Momentum

68

Gaining

Sentiment

59

Mixed

Risk resilience

66

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

AMN Healthcare Services, Inc. (AMN) specializes in delivering comprehensive workforce solutions and staffing services to hospitals and healthcare facilities throughout the United States. Its operations are structured across three primary segments: The Nurse and Allied Solutions segment focuses on placing registered nurses in travel assignments, rapid response roles during emergencies or labor disruptions, and local positions. It also supplies allied health professionals for various roles and offers revenue cycle management solutions. Through its Physician and Leadership Solutions segment, AMN facilitates the placement of locum tenens physicians for temporary assignments, provides interim leadership for healthcare organizations, conducts executive searches, and handles permanent physician recruitment. Lastly, the Technology and Workforce Solutions segment encompasses services like language interpretation, vendor management systems (VMS), workforce optimization strategies, telehealth platforms, credentialing assistance, and various outsourced solutions. Beyond nurses and physicians, AMN's network of professionals includes a broad spectrum of allied health specialists such as physical, respiratory, and occupational therapists; medical and radiology technologists; lab technicians; speech pathologists; rehabilitation assistants; and pharmacists. The company leverages numerous recognized brands to deliver its services, including American Mobile, Nursefinders, NurseChoice, HealthSource Global Staffing, Onward Healthcare, O'Grady Peyton International, Med Travelers, Club Staffing, Staff Care, B.E. Smith, Merritt Hawkins, AMN Revenue Cycle Solutions, and AMN Language Services. Established in 1985, AMN Healthcare is headquartered in Dallas, Texas.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
US
CEO
Caroline Sullivan Grace
Listed since
Nov 13, 2001
Employees
2,664

Market position

Day range

Current $34.175

52-week range

Current $34.175

Open
$34.47
Previous close
$34.46
Volume
154.31K
0.16× average
Average volume
973.91K
Average daily volume
Market cap
1.33B USD
Beta
0.39
Market reference 1
50-day average
$33.2366
+2.82% above average
200-day average
$23.3675
+46.25% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
1.38B USD
P/E (TTM)
12.66×
P/B (TTM)
1.8×
P/S (TTM)
0.39×
EV / EBITDA
13.61×
Earnings yield
-15.76%
Free cash flow yield
38.52%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
27.79%
Operating margin
4.68%
Net margin
3.05%
Return on equity
-14.90%
Return on assets
-4.57%
Return on invested capital
2.06%

Financial health

Debt / equity
1.05×
Current ratio
0.94×
Altman Z-score
3.04
Piotroski F-score
8 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends37%22%6%-9%Gross margin, FY2021: 32.87%Gross margin, FY2022: 32.74%Gross margin, FY2023: 32.98%Gross margin, FY2024: 30.81%Gross margin, FY2025: 28.35%Operating margin, FY2021: 12.00%Operating margin, FY2022: 12.34%Operating margin, FY2023: 8.93%Operating margin, FY2024: -3.44%Operating margin, FY2025: 1.21%Net margin, FY2021: 8.22%Net margin, FY2022: 8.47%Net margin, FY2023: 5.56%Net margin, FY2024: -4.93%Net margin, FY2025: -3.51%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 32.87%. Gross margin FY2022 32.74%. Gross margin FY2023 32.98%. Gross margin FY2024 30.81%. Gross margin FY2025 28.35%. Operating margin FY2021 12.00%. Operating margin FY2022 12.34%. Operating margin FY2023 8.93%. Operating margin FY2024 -3.44%. Operating margin FY2025 1.21%. Net margin FY2021 8.22%. Net margin FY2022 8.47%. Net margin FY2023 5.56%. Net margin FY2024 -4.93%. Net margin FY2025 -3.51%.

Income trends

Revenue

2.73B USD-8.49%

Operating income

33.17M USD+135.84M USD

Net income

−95.7M USD+34.89%
Income trends across reported periods5.78B USD3.63B USD1.47B USD−686M USDRevenue, FY2021: 3.98B USDRevenue, FY2022: 5.24B USDRevenue, FY2023: 3.79B USDRevenue, FY2024: 2.98B USDRevenue, FY2025: 2.73B USDOperating income, FY2021: 478M USDOperating income, FY2022: 647.1M USDOperating income, FY2023: 338.43M USDOperating income, FY2024: −102.67M USDOperating income, FY2025: 33.17M USDNet income, FY2021: 327.39M USDNet income, FY2022: 444.05M USDNet income, FY2023: 210.68M USDNet income, FY2024: −146.98M USDNet income, FY2025: −95.7M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 3.98B USD. Revenue FY2022 5.24B USD. Revenue FY2023 3.79B USD. Revenue FY2024 2.98B USD. Revenue FY2025 2.73B USD. Operating income FY2021 478M USD. Operating income FY2022 647.1M USD. Operating income FY2023 338.43M USD. Operating income FY2024 −102.67M USD. Operating income FY2025 33.17M USD. Net income FY2021 327.39M USD. Net income FY2022 444.05M USD. Net income FY2023 210.68M USD. Net income FY2024 −146.98M USD. Net income FY2025 −95.7M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue2.73B USD2.98B USD3.79B USD5.24B USD3.98B USD
Cost of goods sold1.96B USD2.06B USD2.54B USD3.53B USD2.67B USD
Gross profit774.06M USD919.38M USD1.25B USD1.72B USD1.31B USD
Selling, general, and administrative593.02M USD632.49M USD756.24M USD936.58M USD730.45M USD
Operating expenses740.89M USD1.02B USD911.15M USD1.07B USD831.6M USD
Interest expense45.59M USD69.9M USD54.14M USD40.4M USD34.08M USD
Depreciation and amortization156.6M USD173.78M USD160.93M USD137.11M USD103.7M USD
Operating income33.17M USD−102.67M USD338.43M USD647.1M USD478M USD
Net income−95.7M USD−146.98M USD210.68M USD444.05M USD327.39M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
91%
10 beats, 0 misses, 1 met estimate
Average EPS surprise
+67.89%
11 comparable reports
Latest EPS result
0.77
Estimate 0.19 · Beat by 307.84%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates2.251.550.850.14Q1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26MetQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 20, 2025: actual 0.75, estimate 0.52, surprise +44.23%, Beat. Q2 2025, reported May 8, 2025: actual 0.45, estimate 0.19, surprise +136.84%, Beat. Q3 2025, reported Aug 7, 2025: actual 0.3, estimate 0.17, surprise +76.47%, Beat. Q4 2025, reported Nov 6, 2025: actual 0.39, estimate 0.19, surprise +105.26%, Beat. Q1 2026, reported Feb 19, 2026: actual 0.22, estimate 0.22, surprise 0.00%, Met estimate. Q2 2026, reported May 7, 2026: actual 2.1, estimate 1.6, surprise +31.25%, Beat. Q3 2026, reported Aug 6, 2026: actual 0.77, estimate 0.189, surprise +307.84%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 0.2, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates1.44B1.15B858.38M568.39MQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25MissQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 20, 2025: actual 734.71M USD, estimate 694.38M USD, surprise +5.81%, Beat. Q2 2025, reported May 8, 2025: actual 689.53M USD, estimate 670.08M USD, surprise +2.90%, Beat. Q3 2025, reported Aug 7, 2025: actual 658.18M USD, estimate 639.64M USD, surprise +2.90%, Beat. Q4 2025, reported Nov 6, 2025: actual 634.5M USD, estimate 723.12M USD, surprise -12.26%, Miss. Q1 2026, reported Feb 19, 2026: actual 748.23M USD, estimate 723.7M USD, surprise +3.39%, Beat. Q2 2026, reported May 7, 2026: actual 1.38B USD, estimate 1.23B USD, surprise +11.74%, Beat. Q3 2026, reported Aug 6, 2026: actual 673.2M USD, estimate 628.39M USD, surprise +7.13%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 648.93M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$33.50

1.98% downside
Past 12 months12-month forecastHigh $40.00Average $33.50Low $26.00

Rating distribution

17 ratings
Strong buy00%
Buy1059%
Hold635%
Sell16%
Strong sell00%

Recent analyst actions

11 institutions
Citizens Capital MarketsmaintainMarket Outperform

AMN news

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

$1.20

2011 complete year-71.4% since 2010

Corporate action history

Dividend

Ex-dividend Sep 29, 2011

$0.30

Quarterly

Dividend

Ex-dividend Jul 26, 2011

$0.30

Quarterly

Payment Aug 16, 2011

Dividend

Ex-dividend Apr 26, 2011

$0.30

Quarterly

Payment May 17, 2011

Dividend

Ex-dividend Jan 25, 2011

$0.30

Quarterly

Payment Feb 15, 2011

Dividend

Ex-dividend Nov 8, 2010

$3.00

Monthly

Payment Nov 30, 2010

Dividend

Ex-dividend Oct 26, 2010

$0.30

Quarterly

Payment Nov 16, 2010

AMN peers

ETFs holding AMN

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research AMN

research.disclaimer